Pro Share Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.01 - $1.36 $3,786 - $5,098	-3,749 Reduced 21.48%	13,701 $15,000
Q1 2024 May 08, 2024	BUY	$0.92 - $1.44 $1,315 - $2,059	1,430 Added 8.93%	17,450 $21,000
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $1,511 - $15,322	2,361 Added 17.29%	16,020 $16,000
Q3 2023 Nov 13, 2023	BUY	$6.56 - $10.95 $347 - $580	53 Added 0.39%	13,659 $93,000
Q2 2023 Aug 10, 2023	BUY	$7.89 - $10.64 $10,872 - $14,661	1,378 Added 11.27%	13,606 $141,000
Q1 2023 May 11, 2023	SELL	$7.07 - $17.95 $11,312 - $28,720	-1,600 Reduced 11.57%	12,228 $98,000
Q4 2022 Feb 02, 2023	BUY	$14.33 - $18.37 $15,734 - $20,170	1,098 Added 8.63%	13,828 $217,000
Q3 2022 Nov 04, 2022	BUY	$13.07 - $18.22 $10,756 - $14,995	823 Added 6.91%	12,730 $201,000
Q2 2022 Aug 01, 2022	SELL	$10.16 - $17.08 $40,619 - $68,285	-3,998 Reduced 25.14%	11,907 $167,000
Q1 2022 May 10, 2022	SELL	$9.74 - $17.92 $37,547 - $69,081	-3,855 Reduced 19.51%	15,905 $274,000
Q4 2021 Feb 08, 2022	BUY	$12.27 - $18.49 $242,455 - $365,362	19,760 New	19,760 $287,000
Q3 2021 Nov 12, 2021	SELL	$13.38 - $18.8 $150,712 - $211,763	-11,264 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $192,389 - $333,414	11,264 New	11,264 $198,000
Q4 2019 Feb 12, 2020	SELL	$1.02 - $1.97 $15,004 - $28,978	-14,710 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$0.79 - $2.47 $859 - $2,687	-1,088 Reduced 6.89%	14,710 $16,000
Q2 2019 Aug 13, 2019	SELL	$2.13 - $7.06 $4,168 - $13,816	-1,957 Reduced 11.02%	15,798 $35,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $833 - $1,160	148 Added 0.84%	17,755 $106,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $10,735 - $26,241	1,704 Added 10.71%	17,607 $130,000
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $8,728 - $12,680	-607 Reduced 3.68%	15,903 $231,000
Q2 2018 Aug 13, 2018	SELL	$16.46 - $20.33 $11,818 - $14,596	-718 Reduced 4.17%	16,510 $330,000
Q1 2018 May 14, 2018	SELL	$17.08 - $25.64 $48,455 - $72,740	-2,837 Reduced 14.14%	17,228 $302,000
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $430,795 - $557,807	20,065	20,065 $495,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account